Jan joined the Institute of Biomedical Sciences in 2019 to investigate how biomaterials can be used to drive stem cell behavior. His initial research focused on understanding the molecular interactions of stem cells with artificial (3D printed) extracellular matrices and designing these systems to stimulate targeted differentiation. During his PhD, he concentrated on molecular signaling networks in cancer cells, leveraging multi-omics approaches to discover novel predictive biomarkers for personalized medicine—a line of research he continues today with a specific focus on cannabinoids. 

Currently, Jan’s research focuses extensively on cannabinoid science. He investigates the role of cannabinoids in modulating signaling pathways and molecular mechanisms in cancer, with the aim of advancing personalized therapeutic strategies. His work bridges basic research and clinical applications, exploring how cannabinoids interact with cancer cells and the tumor microenvironment to influence disease progression and treatment outcomes. 

Jan holds an MSc in Biotechnology and Business from Oxford Brookes University and a PhD in Biomedical Sciences from Luxembourg University.